# DMAC (Diamedica Therapeutics Inc.) - SEC EDGAR Financial Statements

> Diamedica Therapeutics Inc. reported $36.15M in total assets and a net loss of $40.23M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/DMAC
- Markdown: https://convexityos.com/fundamentals/DMAC.md
- SEC CIK: 0001401040
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:35 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001401040&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$41.81M | Operating profit |
| Net Income | FY 2025 | -$40.23M | GAAP bottom line |
| Diluted EPS | FY 2025 | -- | Split-adjusted |
| Free Cash Flow | FY 2025 | -$33.82M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $34.91M | Total debt: $157K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | -- | $500K | -- |
| Research & Development | $24.61M | $19.06M | $13.11M | $7.84M | $8.77M | $8.21M | $7.90M | $4.52M | $3.21M |
| Total Operating Expenses | $34.40M | $26.68M | $21.27M | $14.00M | $13.65M | $12.70M | $11.59M | $7.26M | $4.52M |
| **Operating Income** | -$34.40M | -$26.68M | -$21.27M | -$14.00M | -$13.65M | -$12.70M | -$11.59M | -$6.76M | -$4.52M |
| **EBITDA** | -$34.35M | -$26.64M | -$21.24M | -$13.98M | -$13.62M | -$12.68M | -$11.57M | -$6.75M | -$4.51M |
| Interest Income | $1.67M | $2.30M | $1.95M | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$32.74M | -$24.41M | -$19.34M | -$13.65M | -$13.56M | -$12.27M | -$10.62M | -$5.65M | -$4.26M |
| Income Tax Expense | $28K | $30K | $43K | $28K | $28K | $27K | $31K | $80K | -- |
| **Net Income** | -$32.77M | -$24.44M | -$19.38M | -$13.68M | -$13.59M | -$12.29M | -$10.65M | -$5.73M | -$4.26M |
| Basic EPS | -$0.70 | -$0.60 | -$0.60 | -$0.52 | -$0.65 | -$0.78 | -$0.89 | -$0.74 | -$0.72 |
| **Diluted EPS** | -- | -- | -- | -- | -$0.65 | -$0.78 | -$0.89 | -$0.74 | -$0.72 |
| Basic Shares Outstanding | 47.0M | 40.4M | 32.6M | 26.4M | 20.8M | 15.7M | 12.0M | 7.7M | 5.9M |
| Diluted Shares Outstanding | -- | -- | -- | -- | 20.8M | 15.7M | 12.0M | 7.7M | 5.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $9.24M | $8.15M | $7.99M | $6.70M | $6.44M | $5.82M | $5.66M | $6.47M |
| **Operating Income** | -$11.62M | -$10.50M | -$10.48M | -$9.21M | -$9.03M | -$8.01M | -$8.14M | -$8.42M |
| **EBITDA** | -$11.61M | -$10.49M | -$10.47M | -$9.20M | -$9.02M | -$8.00M | -$8.13M | -$8.41M |
| Interest Income | -- | -- | $470K | $472K | $440K | $313K | $444K | $543K |
| Income Before Tax | -$11.30M | -$10.13M | -$10.04M | -$8.73M | -$8.61M | -$7.69M | -$7.70M | -$7.89M |
| Income Tax Expense | $8.0K | $7.0K | $7.0K | $10K | $6.0K | $6.0K | $6.0K | $9.0K |
| **Net Income** | -$11.31M | -$10.14M | -$10.04M | -$8.74M | -$8.62M | -$7.70M | -$7.71M | -$7.90M |
| Basic EPS | -$0.21 | -$0.19 | -$0.19 | -- | -$0.17 | -$0.18 | -$0.18 | -- |
| Basic Shares Outstanding | 53.9M | 53.9M | 53.8M | -- | 49.6M | 43.0M | 42.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $15.65M | $3.02M | $4.54M | $4.73M | $4.71M | $7.41M | $3.88M | $16.82M | $1.35M |
| Short-Term Investments | $44.24M | $41.12M | $48.35M | $28.77M | $40.41M | $20.10M | $4.00M | -- | -- |
| **Cash & Short-Term Investments** | $59.90M | $44.10M | $52.90M | $33.50M | $45.11M | $27.51M | $7.90M | $16.82M | $1.35M |
| Accounts Receivable, Net | $258K | $236K | $369K | $82K | $130K | $340K | $823K | $780K | $80K |
| **Total Current Assets** | $60.63M | $44.61M | $53.67M | $33.84M | $45.44M | $27.92M | $8.84M | $17.97M | $1.49M |
| Property, Plant & Equipment, Net | $145K | $148K | $131K | $136K | $70K | $74K | $64K | $96K | $37K |
| Long-Term Investments | -- | $0 | -- | $0 | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $742K | $1.74M | $485K | $560K | $112K | $174K | $217K | $367K | $308K |
| **Total Assets** | $61.37M | $46.34M | $54.16M | $34.40M | $45.55M | $28.09M | $9.05M | $18.34M | $1.80M |
| Accounts Payable | $1.48M | $940K | $926K | $734K | $509K | $1.10M | $182K | $483K | $513K |
| **Total Current Liabilities** | $5.13M | $5.39M | $2.79M | $2.17M | $1.52M | $2.03M | $1.32M | $1.30M | $1.00M |
| **Total Non-Current Liabilities** | $128K | $237K | $317K | $400K | $3.0K | $53K | $118K | $18K | $0 |
| **Total Liabilities** | $5.26M | $5.63M | $3.10M | $2.57M | $1.53M | $2.08M | $1.44M | $1.31M | $1.00M |
| **Total Debt (incl. Leases)** | $240K | $340K | $400K | $469K | $90K | $118K | $178K | $23K | -- |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | -- | -- | -- |
| Retained Earnings | -$172.8M | -$140.0M | -$115.6M | -$96.18M | -$82.50M | -$68.91M | -$56.62M | -$45.97M | -$40.23M |
| Accumulated Other Comp. Income | $50K | $23K | $6.0K | -$74K | -$51K | -$2.0K | $2.0K | -- | -- |
| **Total Stockholders' Equity** | $56.11M | $40.72M | $51.06M | $31.83M | $44.02M | $26.01M | $7.62M | $17.02M | $799K |
| Total Equity | $56.11M | $40.72M | $51.06M | $31.83M | $44.02M | $26.01M | $7.62M | $17.02M | $799K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $6.80M | $5.13M | $4.87M | $15.65M | $3.33M | $4.11M | $2.59M | $3.02M |
| Short-Term Investments | $28.11M | $38.38M | $46.46M | $44.24M | $51.99M | $25.93M | $33.73M | $41.12M |
| **Cash & Short-Term Investments** | $34.90M | $43.50M | $51.30M | $59.90M | $55.30M | $30.00M | $37.30M | $44.10M |
| Accounts Receivable, Net | $176K | $244K | $301K | $258K | $260K | $161K | $253K | $236K |
| **Total Current Assets** | $35.49M | $44.31M | $52.36M | $60.63M | $56.22M | $31.08M | $37.42M | $44.61M |
| Property, Plant & Equipment, Net | $131K | $133K | $142K | $145K | $150K | $152K | $149K | $148K |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | $1.00M | $0 |
| **Total Non-Current Assets** | $661K | $686K | $717K | $742K | $824K | $391K | $1.41M | $1.74M |
| **Total Assets** | $36.15M | $45.00M | $53.08M | $61.37M | $57.05M | $31.47M | $38.83M | $46.34M |
| Accounts Payable | $2.65M | $2.81M | $3.29M | $1.48M | $1.92M | $1.26M | $1.51M | $940K |
| **Total Current Liabilities** | $7.45M | $6.59M | $5.75M | $5.13M | $5.27M | $4.12M | $4.67M | $5.39M |
| **Total Non-Current Liabilities** | $40K | $69K | $97K | $128K | $157K | $184K | $211K | $237K |
| **Total Liabilities** | $7.49M | $6.66M | $5.84M | $5.26M | $5.42M | $4.30M | $4.88M | $5.63M |
| **Total Debt (incl. Leases)** | $157K | $185K | $212K | $240K | $266K | $292K | $316K | $340K |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$204.3M | -$192.9M | -$182.8M | -$172.8M | -$164.0M | -$155.4M | -$147.7M | -$140.0M |
| Accumulated Other Comp. Income | -$55K | -$37K | -$26K | $50K | $50K | -$14K | $5.0K | $23K |
| **Total Stockholders' Equity** | $28.66M | $38.34M | $47.23M | $56.11M | $51.62M | $27.17M | $33.95M | $40.72M |
| Total Equity | $28.66M | $38.34M | $47.23M | $56.11M | $51.62M | $27.17M | $33.95M | $40.72M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$32.77M | -$24.44M | -$19.38M | -$13.68M | -$13.59M | -$12.29M | -$10.65M | -$5.73M | -$4.26M |
| Depreciation & Amortization | $43K | $39K | $30K | $25K | $24K | $21K | $21K | $15K | $4.0K |
| Stock-Based Compensation | $3.85M | $2.08M | $1.68M | $1.50M | $1.56M | $1.84M | $1.16M | $620K | $409K |
| Change in Receivables | -$22K | $133K | -$287K | $48K | $210K | $483K | -$43K | -$700K | -$27K |
| Change in Payables | $535K | $14K | $192K | $225K | -$590K | $917K | -$301K | -$30K | -- |
| **Operating Cash Flow** | -$29.06M | -$22.08M | -$18.73M | -$11.51M | -$12.25M | -$9.19M | -$9.10M | -$5.70M | -$3.90M |
| Capital Expenditure | -$40K | -$25K | -$24K | -$81K | -$22K | -$47K | -$2.0K | -$50K | -$22K |
| **Free Cash Flow** | -$29.10M | -$22.10M | -$18.75M | -$11.59M | -$12.27M | -$9.23M | -$9.10M | -$5.75M | -$3.92M |
| Purchases of Investments | -$59.28M | -$50.41M | -$69.41M | -$45.68M | -$69.81M | -$39.75M | -$12.92M | -- | -- |
| **Investing Cash Flow** | -$2.19M | $8.56M | -$18.30M | $11.54M | -$20.54M | -$16.13M | -$3.91M | -$50K | -$22K |
| Common Stock Issued | $43.28M | $11.75M | $36.85M | $0 | $29.85M | $28.80M | -- | $14.73M | $2.92M |
| **Financing Cash Flow** | $43.88M | $11.99M | $36.84M | -$6.0K | $30.09M | $28.84M | $70K | $21.22M | $3.54M |
| **Net Change in Cash** | $12.62M | -$1.52M | -$185K | $21K | -$2.70M | $3.53M | -$12.94M | $15.47M | -$383K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$11.31M | -$10.14M | -$10.04M | -$8.74M | -$8.62M | -$7.70M | -$7.71M | -$7.90M |
| Depreciation & Amortization | $12K | $12K | $11K | $11K | $18K | $3.0K | $11K | $11K |
| Stock-Based Compensation | $1.53M | $1.12M | $822K | $1.19M | $1.02M | $771K | $867K | $589K |
| Change in Receivables | $68K | $57K | -$43K | $2.0K | -$99K | $92K | -$17K | $54K |
| Change in Payables | -$166K | -$481K | $1.82M | -$445K | $659K | -$246K | $567K | -$231K |
| **Operating Cash Flow** | -$8.83M | -$8.11M | -$9.08M | -$7.76M | -$6.55M | -$7.60M | -$7.15M | -$6.43M |
| Capital Expenditure | -$10K | -$3.0K | -$8.0K | -$6.0K | -$16K | -$6.0K | -$12K | -$7.0K |
| **Free Cash Flow** | -$8.84M | -$8.12M | -$9.09M | -$7.77M | -$6.57M | -$7.60M | -$7.16M | -$6.44M |
| Purchases of Investments | -$5.92M | -$4.75M | -$18.90M | -$8.05M | -$34.85M | -$9.50M | -$6.87M | -$10.79M |
| **Investing Cash Flow** | $10.39M | $8.24M | -$2.11M | $8.00M | -$25.77M | $8.96M | $6.62M | $5.21M |
| **Financing Cash Flow** | $114K | $132K | $417K | $12.09M | $31.53M | $161K | $91K | $120K |
| **Net Change in Cash** | $1.67M | $261K | -$10.78M | $12.32M | -$783K | $1.52M | -$436K | -$1.11M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -1352.2% | -- |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -1146.8% | -- |
| Return on Equity (ROE) | -58.4% | -60.0% | -38.0% | -43.0% | -30.9% | -47.3% | -139.8% | -33.7% | -533.2% |
| Return on Assets (ROA) | -53.4% | -52.7% | -35.8% | -39.8% | -29.8% | -43.8% | -117.6% | -31.3% | -236.4% |
| Current Ratio | 11.81x | 8.28x | 19.27x | 15.61x | 29.82x | 13.77x | 6.70x | 13.87x | 1.49x |
| Quick Ratio | 11.72x | 8.23x | 19.12x | 15.49x | 29.69x | 13.73x | 6.62x | 13.58x | 1.43x |
| Debt to Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.02x | 0.00x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -140.4% | -97.9% | -74.3% | -58.4% | -61.8% | -108.9% | -79.5% | -60.0% |
| Return on Assets (ROA) | -111.3% | -83.4% | -66.1% | -53.4% | -56.0% | -94.0% | -69.5% | -52.7% |
| Current Ratio | 4.76x | 6.72x | 9.11x | 11.81x | 10.67x | 7.55x | 8.02x | 8.28x |
| Quick Ratio | 4.71x | 6.63x | 8.98x | 11.72x | 10.55x | 7.33x | 8.05x | 8.23x |
| Debt to Equity | 0.01x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
